Article information
Full text is only aviable in PDF
Bibliografía
[1.]
D.R. Park, S.J. Skerrett.
The usefullness of the sputum Gram stain in the diagnosis of pneumonia.
Clin Pulm Med, 2 (1995), pp. 201-212
[2.]
M. Kalin, A. Lindberg, E. Olausson.
Diagnosis of pneumococcal pneumonia by coagglutination and counterimmunoelectrophoresis of sputum samples.
Eur J Clin Microbiol, 1 (1982), pp. 91-96
[3.]
A. Torres, J. Serra-battles, A. Ferrer, P. Jiménez, R. Celis, E. Cobo, et al.
Severe community-acquired pneumonia: epidemiology and prognostic factors.
Am Rev Respir Dis, 144 (1991), pp. 312-318
[4.]
T.J. Marrie.
Bacteremic pneumococcal pneumonia: a continuously evolving disease.
J Infect, 242 (1992), pp. 47-55
[5.]
R. Pallares, J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P.F. Viladrich, et al.
Resistance to penicillin and cephalosporins and mortality from severe pneumococcal pneumonia in Barcelona.
N Engl J Med, 333 (1995), pp. 474-480
[6.]
G.D. Fang, M. Fine, J. Orflof, D. Arisumi, V.L. Yu, W. Kapoor, et al.
New and emerging etiologies for community acquired pneumonia with implications for therapy; a prospective multicenter study of 359 cases.
Medicine (Baltimore), 69 (1990), pp. 307-316
[7.]
M.A. Woodhead, J.T. McFarlane, J.S. McCraken, D.H. Rose, R.G. Finch.
Prospective study on the aetiology and outcome of pneumonia in the community.
Lancet, 1 (1987), pp. 671-674
[8.]
J.G. Bartlett, S.F. Dowell, L.A. Mandell, T.M. File, D.M. Musher, M.J. Fine.
Guidelines from the Infectious Diseases Society of America.
Clin Infect Dis, 31 (2000), pp. 347-382
[9.]
C.M. Luna, E.D. Efron, E. Schiavi, R.J. Gené, A. Famiglietti, E.C. Jolly, et al.
Neumonía adquirida en la comunidad (NAC) en adultos, guía práctica clínica para la Argentina.
Medicina (Buenos Aires), 57 (1997), pp. 343-355
[10.]
J. Almirall, I. Morató, F. Riera, A. Verdaguer, R. Priu, P. Coll, et al.
Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study.
Eur Respir J, 6 (1993), pp. 14-18
[11.]
R. Oseasohn, B.E. Skipper, B. Tempest.
Pneumonia in a Navajo community.
Am Rev Respir Dis, 117 (1978), pp. 1003-1009
[12.]
R. Austrian.
Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccines,
[13.]
C. Jokinen, L. Heiskanen, H. Juvonen, S. Kallinen, K. Karcola, M. Korppi, et al.
Incidence of community-acquired pneumonia in the population of four municipalities in Eastern Finland.
Am J Epidemiol, 137 (1993), pp. 977-988
[14.]
J. Almirall, I. Bolíbar, J. Vidal, G. Sauca, P. Coll, B. Niklasson, et al.
Epidemiology of community-acquired pneumonia in adults: a population- based study.
Eur Respir J, 15 (2000), pp. 757-763
[15.]
B.J. Marston, J.F. Plouffe, J.r. File TM, B.A. Hackman, S.J. Salstrom, H.B. Lipman, et al.
Incidence of community-acquired pneumonia requiring hospitalization: results of a population-based active surveillance study in Ohio.
Arch Intern Med, 157 (1997), pp. 1709-1718
[16.]
Pneumonia and influenza death rates – United States, 1979-1994.
Mmwr Morb Mortal Wkly Rep, 44 (1995), pp. 535-537
[18.]
M.J. Fine, M.A. Smith, C.A. Carson, S.S. Mutha, S.S. Sankey, L.A. Weissfeld, et al.
Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis.
Jama, 275 (1996), pp. 134-141
[19.]
F. Saldías, J. Mardónez, M. Marchesse, P. Viviani, G. Farías, A. Díaz.
Cuadro clínico y factores pronósticos en la neumonía adquirida en la comunidad en adultos hospitalizados.
Rev Med Chil, 130 (2002), pp. 1373-1382
[20.]
R. Menéndez, J. Córdoba, P. De la Cuadra, M.J. Cremades, J.L. López- Hontagas, M. Salavert, et al.
Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.
Am J Respir Crit Care Med, 159 (1999), pp. 1868-1873
[21.]
A. Ruiz, M. Falguera, A. Nogués, M. Rubio.
Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia.
Am J Med, 106 (1999), pp. 385-390
[22.]
E. Berntsson, T. Lagergard, O. Strannegard, B. Trollfors.
Etiology of community-acquired pneumonia in outpatients.
Eur J Clin Microbiol, 5 (1986), pp. 446-447
[23.]
D.B. Langille, L. Yates, T.J. Marrie.
Serological investigation of pneumonia as it presents to the physician's office.
Can J Infect Dis, 4 (1993), pp. 328-332
[24.]
J.T. Macfarlane, A. Colville, A. Guion, R.M. MacFarlane, D.H. Rose.
Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community.
Lancet, 341 (1993), pp. 511-514
[25.]
R. Zalacain, V. Talayero, J. Achótegui, J. Corral, I. Barreña, V. Sobradillo.
Neumonía adquirida en la comunidad. Fiabilidad de los criterios para decidir tratamiento ambulatorio.
Arch Bronconeumol, 33 (1997), pp. 74-79
[26.]
H.M. Foy, M.K. Cooney, R. McMahan, J.T. Grayston.
Viral and mycoplasmal pneumonia in a prepaid medical care group during an eight year period.
Am J Epidemol, 97 (1973), pp. 93-102
[27.]
M. Levy, F. Dromer, N. Brion, F. Leturdu, C. Carbon.
Community acquired pneumonia.
Chest, 92 (1988), pp. 43-48
[28.]
I. Lim, D.R. Shaw, D.P. Stanley, R. Lumb, G. McLennan.
A prospective hospital study of the aetiology of community acquired pneumonia.
Med J Aust, 151 (1989), pp. 87-91
[29.]
A. Porath, F. Schlaeffer, D. Lieberman.
The epidemiology of community- acquired pneumonia among hospitalized adults.
J Infect, 34 (1997), pp. 41-48
[30.]
R. Bohte, R. Van Furth, P.J. Van den Brock.
Aetiology of community- acquired pneumonia: a prospective study among adults requiring admission to hospital.
Thorax, 50 (1995), pp. 543-547
[31.]
Research Committee of the British Thoracic Society. Public Health Laboratory Service.
Community-acquired pneumonia in adults in British Hospitals in 1982-1983: a survey of aetiology, mortality, prognostic factors and outcome.
Q J Med, 62 (1987), pp. 195-220
[32.]
C.M. Luna, A. Famiglietti, R. Absi, A.J. Videla, F.J. Nogueira, A. Díaz Fuenzalida, et al.
Community-acquired pneumonia: etiology, epidemiology and outcome at a teaching hospital in Argentina.
Chest, 118 (2000), pp. 1344-1355
[33.]
J. Blanquer, R. Blanquer, R. Borràs, P. Nauffal, R. Morales, I. Menéndez, et al.
Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study.
Thorax, 46 (1991), pp. 508-511
[34.]
D. Lieberman, F. Schlaeffer, I. Bolden, D. Lieberman, S. Horowitz, M.G. Friedman, et al.
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.
Thorax, 51 (1996), pp. 179-184
[35.]
J. Rello, E. Quintana, V. Ausina, A. Net, G. Prats.
A three-year study of severe community-acquired pneumonia with emphasis on outcome.
Chest, 103 (1993), pp. 232-235
[36.]
P. Moine, J.B. Vercken, S. Chevret, C. Chastang, P. Gajdos.
Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors.
Chest, 105 (1994), pp. 1487-1495
[37.]
M. Ruiz, S. Ewig, A. Torres, F. Arancibia, F. Marco, J. Mensa, et al.
Severe community-acquired pneumonia. Risk factors and followup epidemiology.
Am J Respir Crit Care Med, 160 (1999), pp. 923-929
[38.]
P. Olaechea, J.M. Quintana, M.S. Gallardo, J. Insausti, E. Maravi, B. Álvarez.
A predictive model for the treatment approach to community- acquired pneumonia in patients needing ICU admission.
Intensive Care Med, 22 (1996), pp. 1294-1300
[39.]
N. Hirani, J.T. Macfarlane.
Impact of management guidelines on the outcome of severe community-acquired pneumonia.
Thorax, 52 (1997), pp. 17-21
[40.]
C.M. Luna.
Neumonía por Legionella, un hecho frecuente en Argentina. ¿Diferente epidemiología o marcador del subdesarrollo?.
Medicina (Buenos Aires), 59 (1999), pp. 311-312
[41.]
G. Lopardo, E. Sturba, M.L. Martínez, J.E. Roel, A. Gamba, H. Biondi, et al.
Detección de infección aguda por L. pneumophila en pacientes con neumonía adquirida en la comunidad en la Ciudad de Buenos Aires.
Medicina (Buenos Aires), 62 (2002), pp. 145-148
[42.]
H. Cabello, C. Cortés, M. Ruiz, E. Jover, E. Segovia, M. Luppi, et al.
Neumonía adquirida en la comunidad. Reporte de 8 casos de neumonía grave por Legionella pneumophila serotipo 1 en Chile.
Rev Med Chil, 130 (2002), pp. 309-313
[43.]
T. Lobos, R. Moreno, M. Carstens, A. Doménech, P. Piemonte, C. Juliet, et al.
Seroprevalencia de la infección por Legionella pneumophila en adultos sanos de Santiago de Chile.
Rev Med Chil, 121 (1993), pp. 1123-1127
[46.]
R. Riquelme, A. Torres, M. El-Ebiary, J. Puig de la Bellacasa, R. Estruch, J. Mensa, et al.
Community-acquired pneumonia in the elderly. Clinical and nutritional aspects.
Am J Respir Crit Care Med, 156 (1997), pp. 1908-1914
[47.]
M. Ruiz, S. Ewig, M.A. Marcos, J.A. Martínez, F. Arancibia, J. Mensa, et al.
Etiology of community-acquired pneumonia: impact of age, comorbidity and severity.
Am J Respir Crit Care Med, 160 (1999), pp. 397-405
[48.]
A. Torres, J. Dorca, R. Zalacain, S. Bello, M. El-Ebiary, L. Molinos, et al.
Community-acquired pneumonia in chronic obstructive pulmonary disease. A Spanish multicenter study.
Am J Respir Crit Care Dis, 154 (1996), pp. 1456-1461
[49.]
G.M. Jong, T.R. Hsiue, C.R. Chen, H.Y. Chang, C.W. Chen.
Rapidly fatal outcome of bacteriemic Klebsiella pneumoniae pneumonia in alcoholics.
Chest, 107 (1995), pp. 214-217
[50.]
D. Steinhoff, H. Lode, G. Ruckdeschel, B. Heidrich, A. Rolfs, F.J. Fehrenbach, et al.
Chlamydia pneumoniae as a cause of community- acquired pneumonia in hospitalized patients in Berlin.
Clin Infect Dis, 22 (1996), pp. 958-964
[51.]
T. Lobos, F. Saldías, C. Cartagena, E. Jover, M. Álvarez, R. Moreno.
Chlamydia pneumoniae en pacientes con neumonías adquiridas en la comunidad en Santiago de Chile.
Rev Med Chile, 126 (1998), pp. 1483-1488
[52.]
T.M. File, J.S. Tan.
Incidence, etiologic pathogens, and diagnostic testing of community-acquired pneumonia.
Curr Opin Pulm Med, 3 (1997), pp. 89-97
[53.]
R.P. Wenzel.
A new hantavirus infection in North America.
N Engl J Med, 330 (1994), pp. 1004-1005
[54.]
M.E. Lázaro, A.J. Resa, C.M. Barclay, L. Calanni, L. Samengo, P.J. Padula, et al.
Síndrome pulmonar por hantavirus en el sur andino argentino.
Medicina (Buenos Aires), 60 (2000), pp. 289-301
[55.]
C. Castillo, J. Naranjo, A. Sepúlveda, G. Ossa, H. Levy.
Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults.
Chest, 120 (2001), pp. 548-554
[56.]
K.W. Tsang, P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, M. Chang-Yeung, et al.
A cluster of cases of severe acute respiratory syndrome in Hong Kong.
N Engl J Med, 348 (2003), pp. 1977-1985
[57.]
C.M. Booth, L.M. Matukas, G.A. Tomlinson, A.R. Rachlis, D.B. Rose, H.A. Dwosh, et al.
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Jama, 289 (2003), pp. 2801-2809
[58.]
D. Felmingham, R.N. Gruneberg.
The Alexander Project 1996- 1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
J Antimicrob Chemother, 45 (2000), pp. 191-203
[59.]
C.G. Whitney, M.M. Farley, J. Hadler, et al.
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States.
N Engl J Med, 343 (2000), pp. 1917-1924
[60.]
T. Soler, L. Salamanca, G. Arbo, E. Molina.
Susceptibilidad in vitro de cepas de Streptococcus pneumoniae aisladas de infecciones de las vías aéreas inferiores en el Instituto Nacional del Tórax (INT).
Rev Med Chil, 130 (2002), pp. 304-308
[61.]
A. Díaz, C. Torres, L. Flores, P. García, F. Saldías.
Neumonía neumocócica adquirida en la comunidad en adultos hospitalizados.
Rev Med Chil, 131 (2003), pp. 505-514
[62.]
J.D. Heffelfinger, S.F. Dowell, J.H. Jorgensen, K.P. Klugman, L.R. Mabry, D.M. Musher, et al.
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Arch Intern Med, 160 (2000), pp. 1399-1408
[63.]
S. Ewig, M. Ruiz, A. Torres, F. Marco, J.A. Martínez, M. Sánchez, et al.
Pneumonia acquired in the community trough drug-resistant Streptococcus pneumoniae.
Am J Respir Crit Care Med, 159 (1999), pp. 1835-1842
[64.]
M. Guzmán-blanco, J.M. Casellas, H.S. Sader.
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening.
Infect Dis Clin North Am, 14 (2000), pp. 67-81
[65.]
L.L. Dever, H.M. Yassin.
Related articles, links telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections.
Expert Opin Investig Drugs, 10 (2001), pp. 353-367
[66.]
R. Wise, D. Honeybourne.
Pharmacokinetics and pharmacodynamics of fluoroquinolones in the respiratory tract.
Eur Respir J, 14 (1999), pp. 221-229
[67.]
M. Miravitlles.
Moxifloxacin: an antibiotic designed for use in the community.
Eur Respir Rev, 10 (2000), pp. 161-169
[68.]
R. Davidson, R. Cavalcanti, J.L. Brunton, D.J. Bast, J.C.S. De Azavedo, P. Kibsey, et al.
Resistance to levofloxacin and failure to treatment of pneumococcal pneumonia.
N Engl J Med, 346 (2002), pp. 747-750
[69.]
S.L. Kaplan, E.O. Mason Jr..
Management of infections due to antibiotic- resistant Streptococcus pneumoniae.
Clin Microbiol Rev, 11 (1998), pp. 628
[70.]
I. Odenholt, E. Lowdin, O. Cars.
Pharmacodynamics of telithromycin in vitro against respiratory tract pathogens.
Antimicrob Agents Chemother, 45 (2001), pp. 23-29
[71.]
L. Hagberg, A. Torres, D. Van Rensburg, B. Leroy, M. Rangaraju, E. Ruuth.
Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of communityacquired pneumonia.
Infection, 30 (2002), pp. 378-386
[72.]
D. Felmingham.
Evolving resistance patterns in community-acquired respiratory tract pathogens: first results from the PROTEKT Global Surveillance Study.
J Infect, 44 (2002), pp. 3-10
[73.]
H. López, H. Sader, C. Amábile, W. Pedreira, J.L. Muñoz Bellido, J.A. García Rodríguez.
Grupo MSP-LA. Actividad in vitro de moxifloxacino frente a patógenos respiratorios en Iberoamérica.
Rev Esp Quimioterap, 15 (2002), pp. 325-334
[74.]
M.J. Fine, T.E. Auble, D.M. Yealy, B.A. Hanusa, L.A. Weissfeeld, D.E. Singer, et al.
A prediction rule to identify low-risk patients with community-acquired pneumonia.
N Engl J Med, 336 (1997), pp. 243-250
[75.]
B.M. Farr, A.J. Sloman, M.J. Fisch.
Predicting death in patients hospitalized for community-acquired pneumonia.
Ann Intern Med, 115 (1991), pp. 428-436
[76.]
A.M. Fein, S.H. Feinsilver, M.S. Niederman, S. Fiel, P.B. Pai.
When the pneumonia doesn't get better.
Clin Chest Med, 8 (1987), pp. 529-541
[77.]
C.M. Luna, A. Calmaggi, O. Caberloto, J. Gentile, R. Valentín, J. Ciruzzi, et al.
Neumonía adquirida en la comunidad. Guía práctica de manejo elaborada por un comité intersociedades.
Medicina (Buenos Aires), 63 (2003), pp. 319-343
[78.]
S.H. Feinsilver, A.M. Fein, M.S. Niederman, D.E. Schultz, D.H. Faegemburg.
Utility of fiberoptic bronchoscopy in nonresolving pneumonia.
Chest, 98 (1990), pp. 1322-1326
[79.]
A. Ortqvist, M. Kalin, L. Lejdeborn, B. Lundberg.
Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia.
Chest, 97 (1990), pp. 576-582
[80.]
G.M. Eisenberg, H.F. Flippin, H.L. Israel, D.E. Strandness Jr., W. Weiss.
Delayed resolution of pneumonias.
Med Clin North Am, 40 (1956), pp. 1291-1303
[81.]
W.A. Craig.
Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
Clin Infect Dis, 26 (1998), pp. 1-12
[82.]
J.A. Ramírez.
Switch therapy in community-acquired pneumonia.
Diagn Microbiol Infect Dis, 22 (1995), pp. 219-223
[83.]
J.P. Nuorti, J.C. Butler, M.M. Farley, L.H. Harrison, A. McGeer, M.S. Kolczak, et al.
Cigarette smoking and invasive pneumococcal disease.
N Engl J Med, 342 (2000), pp. 681-689
[84.]
K.L. Nichol, L. Baken, A. Nelson.
Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease.
Ann Intern Med, 130 (1999), pp. 397-403
[85.]
World Health Organization.
Pneumococcal vaccines.
Weekly Epidemiological Report, 74 (1999), pp. 177-184
Integrantes del Grupo de Trabajo ALAT
Copyright © 2004. Sociedad Española de Neumología y Cirugía Torácica
